共 103 条
[11]
Xie Y(2013)Primary hepatic neuroendocrine carcinoma: MR imaging findings including preliminary observation on diffusion-weighted imaging Abdom Imaging 38 1269-1276
[12]
Zeng M(2004)Primary neuroendocrine tumors of the liver: MRI features in two cases Abdom Imaging 29 77-81
[13]
Ji Y(2011)Three-phase helical computed tomographic findings of hepatic neuroendocrine tumors: pathologic correlation with revised WHO classification J Comput Assist Tomogr 35 697-702
[14]
Rao S(2013)Primary hepatic neuroendocrine tumor: gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging Acta Radiol Short Rep 2 2047981613482897-509
[15]
Chen C(2015)Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid) AJR Am J Roentgenol 204 498-1311
[16]
Knox CD(2012)Clinical features and outcomes of primary hepatic neuroendocrine carcinomas J Gastroenterol Hepatol 27 1306-3446
[17]
Anderson CD(2016)Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma Eur Radiol 26 3437-378
[18]
Lamps LW(2008)Free-breathing echo-planar imaging based diffusion-weighted magnetic resonance imaging of the liver with prospective acquisition correction J Comput Assist Tomogr 32 372-113
[19]
Adkins RB(2015)Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced mr imaging Radiology 277 104-127
[20]
Pinson CW(2016)Qualitative and quantitative gadoxetic acid-enhanced mr imaging helps subtype hepatocellular adenomas Radiology 279 118-579